Genetic diagnosis of coronary heart disease-associated lipid metabolic disorders;Genetische diagnostik von KHK-assoziierten fettstoffwechselstörungen

Medizinische Genetik

Volumn 16, Issue 3, 2004, Pages 305-308

  Schmitz, Gerd ^a   Langmann, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Apolipoproteins; Atherosclerosis; Lipid metabolism; Molecular genetics; Polymorphisms

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CARRIER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN; PROTEIN NPC1; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

BLOOD VESSEL WALL; CLINICAL GENETICS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLUCOSE METABOLISM; GRANULOCYTE; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOCOMPETENT CELL; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; METABOLIC DISORDER; MOLECULAR GENETICS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; THROMBOCYTE; THROMBOSIS;

EID: 4644356004     PISSN: 09365931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Aslanidis C, Schmitz G (1999) High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clin.Chem. 45:1094-1097.
2. Boekholdt SM, Thompson JF (2003) Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J.Lipid Res. 44:1080-1093.
3. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
4. Cohen JC, Kimmel M, Polanski A, Hobbs HH (2003) Molecular mechanisms of autosomal recessive hypercholesterolemia. Curr.Opin.Lipidol. 14:121-127.
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
6. Ordovas JM (2000) Lipoprotein lipase genetic variation and gender-specific ischemic cerebrovascular disease risk. Nutr.Rev. 58:315-318.
7. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP (1995) Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J.Clin.Invest 95:1225-1234.
8. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat.Genet. 6:29-32.
9. Schmitz G, Langmann T (2001) Structure, function and regulation of the ABC1 gene product. Curr.Opin.Lipidol. 12:129-140.
10. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR (2003) Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler.Thromb.Vasc.Biol. 23:1322-1332.
11. Soufi M, Sattler AM, Maerz W, Starke A, Herzum M, Maisch B, Schaefer JR (2004) A new but frequent mutation of apoB-100-apoB His3543Tyr. Atherosclerosis 174:11-16.
12. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum.Mutat. 21:577-581.